Paul H. Caldron

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 390 citations · Full text

Rheumatoid Disorder, Rheumatology, Spirit-p2 Phase 3 +12

Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index

Barry Skikne, Kari Punnonen, Paul H. Caldron et al. · American Journal of Hematology · 2011 · 222 citations

Dance‐based aerobic exercise for rheumatoid arthritis

Susan G. Perlman, Karen J. Connell, Andrea L. Clark et al. · Arthritis & Rheumatism · 1990 · 69 citations

Physical Activity, Inflammatory Arthritis, Rheumatoid Disorder +18

Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee

Robert M. Levy, S S Kopenkin, B. Ya. Bart et al. · Advances in Therapy · 2010 · 57 citations

Inflammation, Anti-inflammatory, Randomized Multicenter +7

Enteric-coated aspirin bezoar: Elevation of serum salicylate level by barium study

Kathleen Bogacz, Paul H. Caldron · The American Journal of Medicine · 1987 · 53 citations

Allergy, Medicine, Serum Salicylate Level +5